221 related articles for article (PubMed ID: 22201755)
21. Anti-copper therapies in Alzheimer's disease: new concepts.
Squitti R; Zito G
Recent Pat CNS Drug Discov; 2009 Nov; 4(3):209-19. PubMed ID: 19891600
[TBL] [Abstract][Full Text] [Related]
22. Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer's Disease.
Aaseth J; Skalny AV; Roos PM; Alexander J; Aschner M; Tinkov AA
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502369
[TBL] [Abstract][Full Text] [Related]
23. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.
Wang P; Wang ZY
Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171
[TBL] [Abstract][Full Text] [Related]
24. Copper in the brain and Alzheimer's disease.
Hung YH; Bush AI; Cherny RA
J Biol Inorg Chem; 2010 Jan; 15(1):61-76. PubMed ID: 19862561
[TBL] [Abstract][Full Text] [Related]
25. Metals and amyloid-beta in Alzheimer's disease.
Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX
Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549
[TBL] [Abstract][Full Text] [Related]
26. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
[TBL] [Abstract][Full Text] [Related]
27. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
28. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
29. Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis.
Plascencia-Villa G; Perry G
Antioxid Redox Signal; 2021 Mar; 34(8):591-610. PubMed ID: 32486897
[No Abstract] [Full Text] [Related]
30. Trace element alterations in Alzheimer's disease: A review.
Cilliers K
Clin Anat; 2021 Jul; 34(5):766-773. PubMed ID: 33580904
[TBL] [Abstract][Full Text] [Related]
31. d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients.
Squitti R; Rossini PM; Cassetta E; Moffa F; Pasqualetti P; Cortesi M; Colloca A; Rossi L; Finazzi-Agró A
Eur J Clin Invest; 2002 Jan; 32(1):51-9. PubMed ID: 11851727
[TBL] [Abstract][Full Text] [Related]
32. Current understanding of metal ions in the pathogenesis of Alzheimer's disease.
Wang L; Yin YL; Liu XZ; Shen P; Zheng YG; Lan XR; Lu CB; Wang JZ
Transl Neurodegener; 2020; 9():10. PubMed ID: 32266063
[TBL] [Abstract][Full Text] [Related]
33. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models.
Baum L; Ng A
J Alzheimers Dis; 2004 Aug; 6(4):367-77; discussion 443-9. PubMed ID: 15345806
[TBL] [Abstract][Full Text] [Related]
34. The transition metals copper and iron in neurodegenerative diseases.
Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic strategies to prevent Alzheimer's disease pathogenesis using a fluorescent conjugated polyelectrolyte.
Dwivedi AK; Iyer PK
Macromol Biosci; 2014 Apr; 14(4):508-14. PubMed ID: 23836416
[TBL] [Abstract][Full Text] [Related]
36. Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.
Kim N; Lee HJ
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299316
[TBL] [Abstract][Full Text] [Related]
37. Rebalancing metal dyshomeostasis for Alzheimer's disease therapy.
Yang GJ; Liu H; Ma DL; Leung CH
J Biol Inorg Chem; 2019 Dec; 24(8):1159-1170. PubMed ID: 31486954
[TBL] [Abstract][Full Text] [Related]
38. Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment.
Milton NG
Drugs Aging; 2004; 21(2):81-100. PubMed ID: 14960126
[TBL] [Abstract][Full Text] [Related]
39. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
[TBL] [Abstract][Full Text] [Related]
40. Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.
Schrag M; Mueller C; Oyoyo U; Smith MA; Kirsch WM
Prog Neurobiol; 2011 Aug; 94(3):296-306. PubMed ID: 21600264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
